Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure
2022 · Nature Communications · 70 citations
https://doi.org/10.1038/s41467-022-34260-2
C
Christopher Lehmann
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
319
Citations
6
h-index
5
i10-index
Christopher Lehmann is an academic researcher from University of Chicago. The author has contributed to research in topics: Gut microbiota and health & Clostridium difficile and Clostridium perfringens research & Diet and metabolism studies. The author has an h-index of 6, co-authored 30 publications.
ORCID: 0000-0002-1111-2169Papers by this author
worksModifications of microbiome-derived cell-free RNA in plasma discriminates colorectal cancer samples
2025 · Nature Biotechnology · 7 citations
https://doi.org/10.1038/s41587-025-02731-8
Fecal Butyrate and Deoxycholic Acid Concentrations Correlate With Mortality in Patients With Liver Disease
2025 · Gastro Hep Advances · 3 citations
https://doi.org/10.1016/j.gastha.2025.100695
Fecal metabolite profiling identifies critically ill patients with increased 30-day mortality
2025 · Science Advances · 2 citations
https://doi.org/10.1126/sciadv.adt1466
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat